Physician profile
William T Besson
NPI 1790862753
$3,865.31
in general payments reported to CMS, 2019-2025
37 companies · $506 in 2025
The $506 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $362 · 2021: $858 · 2022: $499 · 2023: $603 · 2024: $814 · 2025: $506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,923.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $543.95 | 2019-2025 | Mounjaro, Kisunla |
| Astrazeneca Pharmaceuticals LP | $496.35 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $424.34 | 2021-2025 | Ubrelvy, Vraylar, Qulipta |
| Novo Nordisk INC | $350.60 | 2019-2025 | Ozempic, Rybelsus |
| Daiichi Sankyo INC. | $284.50 | 2020-2024 | Injectafer |
| Exact Sciences Corporation | $163.46 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Boston Scientific Corporation | $153.42 | 2020-2025 | Watchman Flx, Watchman Access System, Ams 700 |
| Amarin Pharma, INC. | $152.32 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $129.98 | 2019-2022 | |
| Pfizer INC. | $129.01 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $114.89 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $102.37 | 2022-2025 | Jardiance |
| Abbott Laboratories | $100.67 | 2021-2025 | Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $97.32 | 2021-2024 | Trelegy Ellipta, Arexvy |
| Novartis Pharmaceuticals Corporation | $87.65 | 2019-2025 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $40.34 | 2021-2023 | Eliquis |
| Upsher-Smith Laboratories LLC | $36.57 | 2020-2021 | |
| Genentech USA, INC. | $36.25 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.88 | 2022-2023 | |
| Idorsia Pharmaceuticals US INC | $33.94 | 2023 | Quviviq |
| Edwards Lifesciences Corporation | $30.65 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Allergan, INC. | $29.42 | 2019-2020 | |
| Stryker Corporation | $28.94 | 2025 | Clottriever Bold Catheter |
| Lundbeck LLC | $28.08 | 2024 | Vyepti |
| Amgen INC. | $25.77 | 2024 | Krystexxa |
| Pulmonx Corporation | $25.72 | 2024 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Cvrx, INC. | $24.99 | 2024-2025 | Barostim Neo System |
| Takeda Pharmaceuticals U.S.A., INC. | $20.21 | 2022 | |
| Esperion Therapeutics, INC. | $19.51 | 2020 | |
| Abiomed | $16.78 | 2025 | |
| Xeris Pharmaceuticals, INC. | $16.21 | 2021 | |
| Phathom Pharmaceuticals, INC. | $16.14 | 2024 | Voquezna |
| Astellas Pharma US INC | $14.64 | 2023 | Veozah |
| Dexcom, INC. | $14.53 | 2023 | Dexcom G6 Transmitter |
| Inari Medical, INC. | $14.48 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Kowa Pharmaceuticals America, INC. | $14.00 | 2021 | |
| Vistapharm, INC. | $12.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Besson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.